Comprehensive Pan-Cancer Analysis Reveals the Potential Biological, Immunological, and Prognostic Value of NKG2A

Figure 3

Comparison of Kaplan–Meier survival curves for differential expression of the NKG2A gene in different cancer types. (a) OS: KM curves of high and low NKGA2 expression in LGG, PCPG, SKCM, UCEC, and THYM patients. (b) DSS: KM curves of high and low NKGA2 expression in CESC, SKCM, UCEC, and THYM patients. (c) DFI: KM curves of high and low NKGA2 expression in ACC, COAD, KIRC, UCEC, HNSC, and THCA patients. (d) PFI: KM curves of high and low NKGA2 expression in ACC, COAD, LGG, SKCM, UCEC, and THCA patients.

(a)

(b)

(c)

(d)